OCT Video Project: Russia-China Prospects in The Pharmaceutical Field

Deepening the strategic partnership between Russia and China in the field of healthcare and pharmaceuticals is becoming a key priority for both countries. This is not only important for government interests, but also has huge potential for companies in the field of pharmaceuticals and biotechnology, as well as for contract research organizations.

OCT, a leading contract research company in Russia and Eastern Europe, is launching a series of videos dedicated to Russian-Chinese prospects in the field of pharmaceuticals. In this series, you will learn about the benefits that Chinese companies can receive by entering the Russian market, the specifics of registering medicines in Russia, and what the Russian market can offer to Chinese sponsors of clinical trials.

The first episode of the video interview series can be viewed at the link below.

Subscribe to our YouTube channel to keep up to date with the main trends in clinical research in Russia.